Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Should we screen for prostate cancer? A re-examination of the evidence

- Featured Image

The potential harms from diagnosis, overdiagnosis and treatment must not be overlooked

Despite the results of two large, but conflicting, trials published side by side in 2009, whether prostate cancer screening is beneficial or harmful (or indeterminate) remains unresolved.1,2 Those on either side of the debate read the same information but interpret it differently, declaring that it supports their unchanged positions.

That prostate cancer is important is not at issue: it is the ninth-ranked cause of disease burden in men in Australia, representing the loss of 36 000 disability-adjusted life-years (DALYs), or 2.7% of the total Australian loss, in 2003.3 This is about two-thirds of the loss resulting from breast cancer in women (60 000 DALYs; 4.8%). A positive family history of prostate cancer is associated with increased risk (typically a risk ratio of about 2),4 although this risk may be exaggerated by detection bias (men with a positive family history are more likely to have a screening test).5 Associations with family history of other conditions…

email